UniMelb Seminar: Commercialising Academic Innovation
Dr Brandy Houser will present her seminar titled "Commercialising Academic Innovation: The Celdara Medical Model as a Case Study" on Thursday, 3 March 2016, from 11 am to 12 midday at the University of Melbourne (Parkville campus).
Abstract: Celdara Medical is a therapeutic and diagnostic development company, focused on bringing the best innovations and discoveries out of leading academic labs and into human trials. It is currently developing a suite of therapeutic products spanning oncology, inflammation, rare disease, and infectious disease. Hundreds of assets per year are evaluated, yielding a robust and diverse early stage pipeline. Celdara Medical operates a CLIA-certified diagnostic lab for subtyping of patients with scleroderma, both for patients and their caregivers, and for drug developers. It currently has 20 employees and generally ~40 individuals engaged via contract or consulting agreements. There are affiliates in Seattle (Virtici LLC) and Wisconsin (TRV) plus an office in New York. Celdara Medical works with researchers at >20 leading research institutions across the country and some internationally. They have partnered a CAR-T cell therapy program (OnCyte) and are continuing to partner with biotech and pharma partners looking to fill their pipelines with high impact, and rigorously vetted assets and innovations.
About: Dr Brandy Houser received her PhD in immunology from Harvard University under the guidance of Dr Jack Strominger for the discovery of specialised macrophage subsets at the human maternal-fetal interface. Currently, at Celdara Medical, Brandy is responsible for the management of the New York/New Jersey office, including sourcing and vetting new pipeline assets. She also leads two pre-clinical development programs in infectious disease and solid organ transplantation.
Further information can be found at: